Bronchogen

Bronchogen ke bioactive short peptide e entsoeng ka li-amino acid tse 'nè; setho sa lelapa la epigenetic regulatory peptides.

 

 

SKU: 198820 Sehlopha:
Arolelana lerato la hau

Bronchogen ke bioactive short peptide e entsoeng ka li-amino acid tse 'nè; setho sa lelapa la epigenetic regulatory peptides. E qaliloe ke sehlopha sa lipatlisiso Setsing sa Bioregulation le Gerontology se St. Petersburg, Russia, e na le litlamorao haholo-holo tse sireletsang le ho lokisa liseleng tsa matšoafo.

Taolo ea polelo ea liphatsa tsa lefutso le tse latelang tlhahiso ea protheine ke mekhoa ea bohlokoa eo litlamorao tsena li kenoang ka eona.

Tatelano

Ala-Glu-Asp-Leu

Nomoro ea CAS

/

Foromo ea limolek'hule

C18H30N4O9

Boima ba Molek'hule

446.45

Patlisiso ea Bronchogen Peptide

1.Chromatin-Ketso e Lebisitsoeng ea Bronchogen ho Tsosolosa Mosebetsi oa Pulmonary

Liphuputso li bontša hore Bronchogen e tlama ka ho toba ho histones (H1, H2b, H3, H4 ke mehlala ea mantlha) le DNA; epigenetic taolo ya diphatsa tsa lefutso tse amanang le tshebetso ya matshwafo e leng sona se tsepamisisang maikutlo.

Mehlala ea liteko e bonts'itse litlamorao tsa ho khutlisa – pneumonia e matla ea baktheria, mefuta e fapaneng ea mafu a sa foleng pulmonary fibrosis, le mefuta e mengata ea kotsi e chefo ea matšoafo.

Ho ntlafatsa morphology le ts'ebetso ea lisele tsa bronchial epithelial ke phello e tsitsitseng ea phekolo ena..

Mokhoa oa ts'ebetso ka boeona o na le likarolo tse ngata, taolo ea epigenetic ho ba tšiea e bohareng, ts'ebetso ea cellular le homeostasis ea lisele tse latelang e le sephetho se tobileng.

2.Gene Expression Regulation: Litla-morao tse khahlanong le ho ruruha le li-antifibrotic

Ho fetola tšebetso ea mongolo ke mokhoa oa bohlokoahali oa Bronchogen.

Mosebetsi oa preclinical o ntse o supa liphatsa tsa lefutso tse susumetsoang ke ona.

Tlhophiso ea lintlha tsa mongolo (le liphatsa tsa lefutso tsa matšoao) e amanang le phapang ea alveolar epithelial e ngotsoe hantle (NKX2-1, Litho tsa lelapa la FOX ke mehlala e meholo).

Liprotheine tsa lekunutu tse kang SCGB1A1/3A2 le tsona lia ameha.

Botšepehi ba sebopeho sa alveolus le tlhahiso ea surfactant li bolokoa ke liphatsa tsa lefutso.

Liphatsa tsa lefutso tse amanang le ho ruruha (CD79A, NOS-3 haeba memori e sebetsa) li laoloa ka tsela e tšoanang – ho ruruha ho feteletseng kapa ho sa laoleheng ke ntlha e kholo ea ho qetela ea lefu la matšoafo, 'me Bronchogen e bonahala bonyane e e fokotsa hanyenyane.

Litlamorao tse khahlanong le ho ruruha le li-anti-fibrotic tsa Bronchogen joale li tšehetsoa hantle mefuteng e mengata.

3.Katoloso ea Lisele le Phapang

Boithuto bo bontša hore Bronchogen e susumetsa liphatsa tsa lefutso tse amanang le potoloho ea lisele le apoptosis.

Ka ho toba, e etsa hore ho be le ponahalo ea lets'oao la ho ata ha lisele, MKI67 (Ki67), le mefuta e fapaneng ea liphatsa tsa lefutso tse khahlanong le apoptotic joalo ka MCL1; mofuta oa mohatelli oa tumor TP53 (p53) ho ba o mong oa mehlala e ithutoang haholo.

Ketso ena ea taolo e thusa ho khothaletsa tokiso ea lisele ka mor'a kotsi, ka khatello ea ho ata ho sa laoleheng ho sa tloaelehang ha lisele e le ntlha e batloang ea ho qetela⁵.

Hajoale Bronchogen e rekisoa haholo e le tlatsetso ea lijo kapa peptide bioregulator – 'Peptide complex bakeng sa tsamaiso ea bronchopulmonary’ ha o ka rata.

Phekolo e ekelitsoeng bakeng sa bronchitis e sa foleng, Lefu le sa foleng le thibelang matšoafo (COPD) le bronchial sefuba ke tšebeliso ea eona e tloaelehileng haholo; tsosolosa (bonyane a sa fella) mosebetsi oa bronchial mucosal, ntlafatso ea mosebetsi oa matšoafo, tlhahiso e ntseng e eketseha ea surfactant 'me ka mor'a moo e khutlisa phokotso e fapaneng ea lilemo ts'ebetsong ea matšoafo ke sepheo sa liphetho..

Ho ntse ho fuputsoa ho kopanya Bronchogen le li-peptide tse ling, ho hlaphoheloa ha tšebetso ea matšoafo ka mor'a COVID-19 e le sebaka se le seng sa thahasello; tokiso ea mofuta oa 'mele le alveolar ka bobeli ho lumeloa hore e laoloa ke eona.

Netefatso ea kliniki ea ts'ebeliso eohle ea hajoale le ea kamoso e ntse e emetse.

COA

HPLC

MOF

(1) Khavinson, V. K.; Popovich, I. G. e.; Lihokelo, N. S.; Mironova, E. S.; Mabitla, A. R. Peptide Regulation ea Gene Expression: Tlhahlobo e Hlophisitsoeng. Limolek'hule 2021, 26 (22). DOI: 10.3390/limolek'hule 26227053.

(2) B. F. Vanyushin, V. K. K. Li-peptide tse Khutšoanyane tsa Biologically Active joalo ka Epigenetic Modulators of Gene Activity. Ho Epigenetics – Mokhoa o fapaneng oa ho sheba liphatsa tsa lefutso Walter Doerfler, P. B. Mong.; 2016; maq 66-90.

(3) Morozova, E. A.; Ke thata, N. S.; Khavinson, V. K.; Soloviev, A. Y.; Kasyanenko, N. A. Tšebelisano ea in vitro ea peptide ea AEDL le DNA. Journal of Structural Chemistry 2017, 58 (2), 420-424. DOI: 10.1134/S0022476617020299.

(4) Hamorao, N. A.; Lebedeva, E. S.; Dvorakovskaya, I. V.; Surkova, E. A.; Platonova, I. S.; ea Tito, O. N. Modulating Effect of Peptide Therapy on the Morphofunctional State of Bronchial Epithelium in Rats with Obstructive Lung Pathology.. Bulletin of Experimental Biology le Medicine 2015, 159 (5), 685-688. DOI: 10.1007/s10517-015-3047-x.

(5) Khavinson, V.; Lihokelo, N.; E ncha, E.; Bolshakova, A.; Gainulina, A.; Tendler, S.; Morozova, E.; Tarnovskaya, S.; Vinski oela, D. S.; Nina Kasyanenko, V. B. Phello ea Neuroprotective ea EDR Peptide ho Mouse Model ea lefu la Huntington. Journal of Neurology le Neuroscience 2017, 08 (01). DOI: 10.21767/2171-6625.1000166.

(6) Khavinson, V.; Lihokelo, N.; Dyatlova, A.; Hoznik, B.; Umnov, R. Li-peptides: Melemo ea ho Sebelisa Phekolong ea COVID-19. Limolek'hule 2020, 25 (19). DOI: 10.3390/limolek'hule 25194389.

Tatelano:

Ala-Glu-Asp-Leu

CAS:

/

M.W:

446.45 g/mol

Lehae Batla Whatsapp Litšebeletso Sehlahisoa